Citation
Print
INTRODUCTION
Traumatic spinal cord injury (SCI) is a clinically irreversible condition and results in catastrophic disability. Acute SCI has two physiological cascading mechanisms2,3). The pathophysiology of acute SCI is complex and occurs via two mechanisms, involving a primary and secondary injury. The primary injury is the initial structural damage caused by a mechanical trauma. The second injury is a subsequent step after the primary injury and can cause a progressive apoptosis caused by local inflammation, production of free radicals, and hyperoxidation5,12,37). Among these mechanisms contributing to secondary injury, inflammatory reactions bring out the reactive astrogliosis, and this reaction produces the glial scar which can be a physical barrier for neuronal regeneration after SCI30). These cascading mechanisms make recovery from SCI hard or impossible. Many methods have been attempted to manage SCI so far. However, there are no fully effective methods. Thus, now in medical science, researching the most effective cure methods for SCI is a crucial task. Stem cell therapy is one of the currently-studied research programs.
According to previous studies, neural stem/progenitor cells (NSPCs) exist in the human adult stage as well as fetal stage11,15). Moreover, recent studies reported that SCI could induce expression of NSPCs, and resulting NSPCs were related to functional and histologic recoveries after SCI8,14,25,29). Stem cell therapy for SCI is focused on clinical usage of NSPCs’ biological activity.
Curcumin (diferuloylmethane) (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a natural ingredient, which has been used as an Indian spice. So far, much research revealed that curcumin has numerous biologic effects, including anti-inflammatory, antioxidant effects10,12,24,27,31,33,34,39). Recent study using a fetal rat brain revealed that curcumin promoted neurogenesis17). However, there have been no in vivo studies to date to reveal whether curcumin affects differentiation and proliferation of spinal cord NSPCs (SC-NSPCs) in the SCI condition.
To date, the NPSC expression, astrogliosis, lesion cavity, and functional recovery effects of curcumin have not been fully evaluated. Therefore, the aim of the present study is to evaluate the effect of curcumin on the expression of SC-NSPCs, reactive astrogliosis, lesion cavity, and functional recovery after SCI.
MATERIALS AND METHODS
Animal population and experimental design
All animal experiments were performed in accordance with the National Institute of Health guidelines on animal care, and were approved by the Institutional Animal Care Committee of our institute. All efforts were made to minimize the number of animals used and animal suffering. Animals were housed in a temperature-controlled room on a 12-hour light/dark circadian cycle.
Culture of SC-NSPC
To establish cultures of SC-NSPCs, Sprague-Dawley rats weighting 250 g to 350 g were sacrificed and their spinal cords were extracted. The spinal cords were chopped using microscissors and incubated in a cocktail containing papain (0.1%; Worthington Biochemical Corp., Lakewood Township, NJ, USA), dispase (0.1%), DNase (0.01%), and MgSO4 (12.4%) in a Hanks balanced salt solution with glucose (0.45%) for 30 minutes at 37°C. The dissociated cells were cultured to form neurospheres in a neurobasal medium containing B-27, glutamin (2 mmol/L), penicillin/streptomycin (0.1 g/mL), fibroblast growth factor-2 (20 ng/mL), and heparin (2 μg/mL). After 7 days, the neurospheres were dissociated with Accutase (Innovative Cell Technologies Inc., San Diego, CA, USA), and 5×105 NSPCs were plated in plates or dishes containing 5 mL of the culture medium. The NSPCs between 5 and 25 passages were used for the experiments.
SC-NSPC proliferation assay
The NSPCs (2×104) were suspended in 100 mL of a neurobasal medium containing various concentrations of curcumin (0.1–30 μmol/L) and cultured in a 96-well plate for 3 days. A 20-mL cell proliferation assay solution containing the tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS, CellTiter 96 Aqueous One Solution; Promega, Madison, WI, USA) was added to the cultured cells and incubated for 2.5 hours at 37°C. The optical density was measured at 490 nm with a microplate spectrophotometer.
SCI models
Total sixty adult male Sprague-Dawley rats weighing 290–310 g (Samtako Bio, Osan, Korea) were randomly and blindly allocated into three groups (n=20 per group). In sham group, only laminectomy was performed without SCI. SCI-curcumin group animals were given a SCI and received 1 μmol/L of curcumin (Sigma-Aldrich, St. Louis, MO, USA) once a day by intrathecal injection. SCI-vehicle group animals were treated with the vehicle only by intrathecal injection following SCI.
The surgical technique used for SCI in rats has been previously described by the authors16,38). Rats were anesthetized via intraperitoneal injection of a mixture of xylazine (10 mg/kg) and ketamine (60 mg/kg). After laminectomy at T9, the extradural plane between the dura and the adjacent vertebrae was carefully dissected. A modified aneurysm clip with a closing force of 30 g (Aesculap, Tuttlingen, Germany) was held in an applicator in the open position. The clip was rapidly released from the applicator and applied vertically onto the exposed spinal cord for a 2-minute compression. For the sham controls, the same surgical procedure was followed, but clip compression was not applied. After surgery, the muscle, fascia, and skin were sutured using a 4–0 silk suture. The rectal temperature was maintained at 37.0±0.5°C by a thermostatically-regulated heating pad during surgery, and during recovery, animals were placed overnight in a temperature- and humidity-controlled chamber. To reduce post-surgery isolation-induced stress, rats were housed in pairs at an ambient temperature of 22–25oC in an alternating 12-hour light/dark cycle. Bladders were manually emptied twice daily until spontaneous voiding occurred (usually within 7–10 days).
Administration of curcumin
The method of constructing and implanting indwelling intrathecal catheters was described previously16,23). Briefly, immediately after SCI or the sham operation, intrathecal catheters were implanted into rats under anesthesia by threading a sterile polyethylene-10 catheter guided by a 20-gauge needle between the L5–6 vertebrae. The catheter was inserted rostrally into the subdural space of the spinal cord. The curcumin were reconstituted in artificial cerebrospinal fluid (ACSF) (119 mmol/L NaCl, 3.1 mmol/L KCl, 1.2 mmol/L CaCl2, 1 mmol/L MgSO4, 0.50 mmol/L KH2PO4, 25 mmol/L NaHCO3, 5 mmol/L D-glucose, and 2.2 mmol/L urea, pH 7.4) at a concentration of 1 μmol/L for curcumin. The control was filled with ACSF alone. Both the compounds were infused for 7 days at a rate of 10 μL per day. To label the proliferating NSPCs, rats were intraperitoneally injected with bromodeoxyuridine (BrdU) (50 mg/kg in saline; Sigma-Aldrich) twice a day for 7 days starting 1 day after the intrathecal injection.
Analysis of newly proliferated SC-NSPC
At 1 week after SCI, six rats from each of the three groups were deeply anesthetized by an intraperitoneal injection of ketamine and were intracardially perfused with 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH=7.4). The thoracic spinal cord was excised, postfixed for 24 hours, and maintained overnight in 30% sucrose in 0.1 M phosphate buffer solution. Spinal cord tissues were sectioned at a thickness of 30 μm on a cryostat, and sections were floated on the surface of 0.1 M phosphate buffer solution. A 5 and 6 mm rostral to the center of injury was performed. To detect nestin (a marker for NSPCs), spinal cord sections were blocked with 4% normal serum in 0.5% Triton X-100 for 1 hour at room temperature, incubated overnight at 4°C with a 1 : 200 dilution of mouse monoclonal anti-nestin (R&D Systems, Inc., Minneapolis, MN, USA) and rabbit polyclonal anti-BrdU (Abcam, Cambridge, MA, USA), and then rinsed for three times for 10 minutes in a 0.1 M PB. Sections were incubated for 2 hours with Alexa Fluor 594 goat anti–mouse IgG and Alexa Fluor 488 goat anti-rabbit IgG (both 1 : 300; invitrogen). The images were viewed on a computer monitor using a Zeiss Plan-Apochromat 40X objective (Carl Zeiss Meditec Inc., Jena, Germany). Enumeration of immune-positive cells used a Labworks, version 4.5, computer-assisted image analyzer (UVP, Upland, CA, USA).
Analysis of peri-lesional astrogliosis
At 4 weeks after SCI, six rats from each of the three groups were sacrificed. Thoracic cord was excised and treated in the same method for analysis of newly proliferated SC-NSPC. A 5 and 6 mm rostral to the center of injury was performed. To detect anti-Glial fibrillary acidic protein (GFAP) (marker for astrocyte), spinal cord sections were blocked. A 1 : 200 dilution of mouse monoclonal anti-GFAP (Abcam) was used. Method of immune-positive cells enumeration is same as assay for newly proliferated SC-NSPC.
Measurement of lesion cavity volume
Six weeks after SCI, eight rats from each of the two groups (SCI-vehicle and SCI-curcumin) were sacrificed. A 1.5 cm segment of the spinal cord centered at the injury site was immediately harvested from the vertebral canal and postfixed in 10% formalin overnight. The portion of the spinal cord was divided into seven segments (4 mm and 2 mm rostral to the lesion; lesion epicenter; 2 mm and 4 mm caudal to the lesion) at 2 mm intervals from the lesion epicenter. Representative sections were sliced into 5 μm-thick sections on the transverse plane and stained with hematoxylin-eosin. To quantitative evaluate of lesion cavity areas, 20 sequential slides of the serial sections were obtained from representative segments. The tissues were examined and photographed using a Zeiss Axioplan microscope (Carl Zeiss Meditec Inc.). The areas of lesion cavity were traced and measured using Axio-Vision 4 software (Carl Zeiss Meditec Inc.).
Locomotor and behavior analyses
The rats were tested for functional deficits for 6 weeks after the surgery using the open field locomotor rating scale developed by the Basso, Beattie, and Bresnahan (BBB) score4). Two evaluators who were unaware of the group allocations and previous functional scores observed each animal for 1 minute. Functional scores for each hind limb were recorded and averaged.
RESULTS
Decision of curcumin concentration to increases the proliferation of SC-NSPCs
To determine the proper concentration of curcumin, SC-NSPCs growing in 96-well plates were maintained in medium lacking or containing various concentrations of curcumin, and the cell proliferation rate was quantified at different time points. After 72 hours of curcumin treatment, curcumin has biphasic effects on SC-NSPC proliferation. Curcumin of 1 μmol/L has most effective in proliferation of NSPC, whereas high dosage (≥5 μmol/L) caused a decrease in NSPC proliferation (Fig. 1).
Newly expressed NSPC at 1 week after SCI
To understand whether curcumin can promote NSPC expression in spinal cord, we infused 1 μmol/L curcumin into the subarachnoid space of adult rats for 7 days after SCI and treated them intraperitoneally with BrdU. The area of the Nestin+/BrdU+ cells in the SCI-curcumin group (183.7±11.5) was significantly increased compared to that in the SCI-vehicle group (97.3±5.4) 1 week after surgery (Fig. 2). This result indicates that curcumin could stimulate the expression of SC-NSPCs after SCI.
Peri-lesional astrogliosis at 4 weeks after SCI
To evaluate whether curcumin can influence the astrogliosis, we checked the GFAP (astrocyte marker). The area of GFAP was remarkably higher in the SCI-vehicle group (69730±1403) compare with the SCI-curcumin group (8034±155) 4 weeks after surgery (Fig 3). This result suggests that curcumin would influence the astrogliosis after SCI.
Lesion cavities
Six weeks following SCI, histological examination revealed a central cavity with peri-lesional regeneration. The lesion cavity extended to over 2 mm rostrally and 2 mm caudally, tapering gradually to cavities affecting the central and dorsal areas of the spinal cord gray and white matter (Fig. 4). In SCI-curcumin group, the area of the lesion cavity was significantly decrease compared to that of the rats that received vehicle solution only (p<0.05). Also, we could find neurogenesis in peri-lesional area.
Locomotor and behavior analysis
The injured rats were assessed for 6 weeks after surgically-induced SCI according to open filed motor testing using the BBB score. While all rats exhibited severe functional impairment following SCI, the motor function of the curcumin-injected rats was markedly better than the vehicle-injected rats 14 days after SCI, which was statistically significant (p<0.05) (Fig. 5). This significance was maintained during 6 weeks and functional improvement was not observed after 3 weeks.
DISCUSSION
Traumatic SCI typically leads to permanent neurological deficits in motor and sensory systems. However, all the general methods, including high-dose steroid therapy, early decompressive surgery, and long-standing rehabilitation, have not been a sufficient solution for recovery from SCI. Inoue reported that axonal regeneration occurred beyond the transection site in young rats and resulted in good functional improvement13). Recently, the proliferation and neuronal differentiation of NSPC after SCI played an important role in functional recovery after SCI14,19,25).
Curcumin’s potentiality to increase the proliferation of NSPCs was already reported in previous studies1,17,22,40). We already reported that curcumin stimulated proliferation of SC-NSPCs through a MAP kinase signaling pathway35). In an extension of our study, we sought to investigate the effect of curcumin on expression of SC-NSPCs and activity of astrogliosis, and functional recovery after SCI in this study. The finding that the proliferation degree of NSPCs depends on dosage of curcumin was verified by recent studies7,28,36). In other words, the proper dosage of curcumin for proliferation of NSPCs has a threshold value. However, the subject of the above studies was not SC-NSPCs. To decide the proper dosage, we used an SC-NSPC proliferation assay, and active SC-NSPC proliferation in the curcumin group compared to the control group was observed in concentrations below 1 μmol/L of curcumin (Fig. 1). In concentrations over 5 μmol/L of curcumin, SC-NSPCs proliferation in the curcumin group sharply decreased with higher concentrations. After work, we administrated 1 μmol/L of curcumin to mice by intrathecal injection every day for 1 week, and after we used immunohistochemistry of nestin & BrdU to evaluate the proliferation of SC-NSPCs by curcumin. According to the study of Shibuya et al.29), we set an evaluation timing of immunofluorescence analysis as 1 week after surgery, because nestin expression peaked at 1 week after surgery in their study. The result of this study showed an increased area of nestin+/Brdu+ cells in the SCI-curcumin group.
In the study of Kim et al.,17) hippocampal neurogenesis was observed in curcumin-administrated adult mice. More recently, in the study of Chen et al.7) using two-thirds of the fetal rat forebrain, differentiation of neural stem cells was checked in the curcumin group. They explained this result in virtue of curcumin’s property to activate the Wnt signaling pathway. In the present study, we used a rat SCI model and observed the decrease of lesion cavity volume (Fig. 4). Also, for the result of BBB score of the entire period, the SCI-curcumin group showed a statistically better motor function than the SCI-vehicle group. Based on these results, we can guess that facilitated proliferation of SC-NSPCs and peri-lesional regeneration induced by curcumin contribute to functional recovery from SCI.
To discuss regeneration in the damaged spinal cord, we cannot help but mention reactive astrogliosis. Astrocytes play a big role as a primary regulator of homeostasis and supporting cells in the normal central nervous system (CNS)9,26). However, in the damaged spinal cord, astrocytes show somewhat different activity in comparison with the normal CNS. After SCI, reactive astrogliosis, which was triggered by proinflammatory cytokines such as TNF-α, IL-1β, and IL-6, arises and this phenomenon changes the damaged spinal cord into a more difficult environment for neurogenesis18,20). Glial scars created by reactive astrogliosis make axonal regeneration difficult as a physical barrier30). Besides, reactive astrocytes secrete the extracellular inhibitory substances, including chondroitin sulfate proteoglycan (CSPG), and axonal regeneration can’t proceed in CSPG-rich regions6,32). In Lin’s study, the reduction of GFAP expression in the SCI-curcumin group was demonstrated21). Their study means that curcumin can inhibit the reactive astrogliosis after SCI. Furthermore, Chen et al.6) reported various roles for curcumin in neuroprotection after SCI. They proved not only decreased expression of GFAP, but decreased expression of proinflammatory cytokines and decreased deposition of CSPG by curcumin. Our study also showed strongly decreased GFAP stain in the SCI-curcumin group compared to the SCI-vehicle group at 4 weeks after surgery (Fig. 3). Considering the lesion cavity and regeneration result of the SCI-curcumin group at 6 weeks after surgery, we can build a reasonable hypothesis that attenuated reactive astrogliosis provides a good circumstance for regeneration after SCI.
XML Download